Studies have shown that keratinocytes, melanocytes, and immune cells express CYP27B1 and related hydroxylases, enabling local synthesis of active Vitamin D metabolites in response to UVB irradiation or inflammatory stimuli [106, 107]
Research from the SUSTAIN and PIONEER trials showed that participants taking semaglutide plus these insulin-releasing drugs experienced more low blood sugar episodes than those on semaglutide alone, though severe hypoglycemia remained uncommon when doses were carefully managed
announced that it has submitted an IND application to the FDA for MBX 4291, a long-acting GLP-1/GIP receptor co-agonist prodrug targeting obesity, which received regulatory clearance in July
(10) In cell cultures of fibroblasts, which are the main type of cell producing collagen in tissues, including ligaments, the peptide appeared to markedly support fibroblast outgrowth, migration, and spreading
Tirzepatide (brand name Mounjaro) is a dual GIP and GLP-1 receptor agonist that helps regulate blood sugar, slow digestion, and suppress appetite
The therapeutic landscape has evolved quickly with the introduction of more potent agents, including semaglutide and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide, which have demonstrated superior efficacy in randomized controlled trials [1, 5, 6]
